JP2011517935A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011517935A5 JP2011517935A5 JP2010550884A JP2010550884A JP2011517935A5 JP 2011517935 A5 JP2011517935 A5 JP 2011517935A5 JP 2010550884 A JP2010550884 A JP 2010550884A JP 2010550884 A JP2010550884 A JP 2010550884A JP 2011517935 A5 JP2011517935 A5 JP 2011517935A5
- Authority
- JP
- Japan
- Prior art keywords
- polymorphism
- nucleic acid
- risk
- item
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6968708P | 2008-03-13 | 2008-03-13 | |
| US61/069,687 | 2008-03-13 | ||
| PCT/US2009/037069 WO2009151691A2 (en) | 2008-03-13 | 2009-03-13 | Genetic polymorphisms associated wiith venous thrombosis, methods of detection and uses thereof |
| US12/403,552 | 2009-03-13 | ||
| US12/403,552 US8071291B2 (en) | 2008-03-13 | 2009-03-13 | Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013212559A Division JP2014003985A (ja) | 2008-03-13 | 2013-10-10 | 静脈血栓症に関連した遺伝子多型、その検出方法および使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011517935A JP2011517935A (ja) | 2011-06-23 |
| JP2011517935A5 true JP2011517935A5 (https=) | 2013-04-04 |
| JP5409658B2 JP5409658B2 (ja) | 2014-02-05 |
Family
ID=41215588
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010550884A Active JP5409658B2 (ja) | 2008-03-13 | 2009-03-13 | 静脈血栓症に関連した遺伝子多型、その検出方法および使用 |
| JP2013212559A Withdrawn JP2014003985A (ja) | 2008-03-13 | 2013-10-10 | 静脈血栓症に関連した遺伝子多型、その検出方法および使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013212559A Withdrawn JP2014003985A (ja) | 2008-03-13 | 2013-10-10 | 静脈血栓症に関連した遺伝子多型、その検出方法および使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (5) | US8071291B2 (https=) |
| EP (1) | EP2276855B1 (https=) |
| JP (2) | JP5409658B2 (https=) |
| CA (1) | CA2717045C (https=) |
| WO (1) | WO2009151691A2 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007000060A (ja) * | 2005-06-23 | 2007-01-11 | Sumitomo Chemical Co Ltd | 昆虫由来のペプチジルジペプチダーゼａ活性に関わる有害生物の生理状態に変化を与える薬剤 |
| WO2009151691A2 (en) * | 2008-03-13 | 2009-12-17 | Celera Corporation | Genetic polymorphisms associated wiith venous thrombosis, methods of detection and uses thereof |
| CA2722238C (en) * | 2008-04-22 | 2017-11-28 | Life Sciences Research Partners Vzw | Liver-specific nucleic acid regulatory elements and methods and use thereof |
| TW201100090A (en) * | 2009-04-01 | 2011-01-01 | Oncotherapy Science Inc | C6orf167 peptides and vaccines containing the same |
| WO2011139387A1 (en) * | 2010-05-03 | 2011-11-10 | Opko Curna, Llc | Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| US11869024B2 (en) * | 2010-09-22 | 2024-01-09 | The Nielsen Company (Us), Llc | Methods and apparatus to analyze and adjust demographic information |
| US20120108651A1 (en) * | 2010-11-02 | 2012-05-03 | Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) | Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof |
| WO2013130868A1 (en) * | 2012-02-29 | 2013-09-06 | Isis Pharmaceuticals, Inc. | Methods for modulating fibrinogen expression |
| US9127274B2 (en) * | 2012-04-26 | 2015-09-08 | Alnylam Pharmaceuticals, Inc. | Serpinc1 iRNA compositions and methods of use thereof |
| US9938576B1 (en) | 2012-09-21 | 2018-04-10 | Ohio State Innovation Foundation | Materials and methods for determining metabolizer status in humans |
| KR102365486B1 (ko) | 2013-08-28 | 2022-02-18 | 아이오니스 파마수티컬즈, 인코포레이티드 | 프리칼리크레인 (pkk) 발현의 조절 |
| US9209571B2 (en) * | 2013-10-16 | 2015-12-08 | Tyco Electronics Corporation | Connector assembly having multiple shield current paths |
| HUE052709T2 (hu) | 2014-05-01 | 2021-05-28 | Ionis Pharmaceuticals Inc | Módosított antiszensz oligonukleotidok konjugátumai és azok alkalmazása PKK expressziójának módosítására |
| GB201410693D0 (en) | 2014-06-16 | 2014-07-30 | Univ Southampton | Splicing modulation |
| AU2015327836B2 (en) | 2014-10-03 | 2021-07-01 | Cold Spring Harbor Laboratory | Targeted augmentation of nuclear gene output |
| EP3212794B1 (en) | 2014-10-30 | 2021-04-07 | Genzyme Corporation | Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof |
| CN105039348B (zh) * | 2015-02-28 | 2019-01-01 | 南开大学 | 具有抑制hiv-1的卷曲螺旋结构蛋白8及其应用 |
| EP3359145B1 (en) | 2015-10-09 | 2025-06-25 | Cleveland State University | Recombinant prothrombin analogues and uses thereof |
| CN108603230A (zh) | 2015-10-09 | 2018-09-28 | 南安普敦大学 | 基因表达的调节与蛋白质表达失调的筛选 |
| KR20180095843A (ko) | 2015-12-07 | 2018-08-28 | 젠자임 코포레이션 | Serpinc1-연관 장애의 치료를 위한 방법 및 조성물 |
| US11096956B2 (en) | 2015-12-14 | 2021-08-24 | Stoke Therapeutics, Inc. | Antisense oligomers and uses thereof |
| WO2017106377A1 (en) | 2015-12-14 | 2017-06-22 | Cold Spring Harbor Laboratory | Antisense oligomers for treatment of autosomal dominant mental retardation-5 and dravet syndrome |
| WO2018104549A1 (en) * | 2016-12-09 | 2018-06-14 | Gene Predictis Sa | Method for predicting the risk of deep vein thrombosis and pulmonary embolism associated with hormonal preparations and hormone levels |
| EP3551762B1 (en) * | 2016-12-09 | 2022-01-26 | Gene Gender S.R.L. | Method and kit for predicting the risk of deep vein thrombosis and pulmonary embolism |
| JP6829878B2 (ja) * | 2017-03-10 | 2021-02-17 | 国立大学法人浜松医科大学 | 加齢黄斑変性の発症リスクの評価方法 |
| KR102318434B1 (ko) | 2017-08-25 | 2021-11-01 | 스톡 테라퓨틱스, 인크. | 병태 및 질환 치료용 안티센스 올리고머 |
| HUE070436T2 (hu) | 2017-10-23 | 2025-06-28 | Stoke Therapeutics Inc | Antiszensz oligomerek nonszensz-mediált RNS-lebomláson alapuló állapotok és betegségek kezelésére |
| CA3099280A1 (en) | 2018-05-04 | 2019-11-07 | Stoke Therapeutics, Inc. | Methods and compositions for treatment of cholesteryl ester storage disease |
| CU20200082A7 (es) | 2018-05-09 | 2021-06-08 | Ionis Pharmaceuticals Inc | Compuestos y métodos para la reducción de la expresión de fxi |
| EP3856224A4 (en) | 2018-09-25 | 2022-07-06 | Emory University | NUCLEIC ACIDS FOR CELL RECOGNITION AND INTEGRATION |
| WO2020136216A1 (en) * | 2018-12-27 | 2020-07-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of identifying subjects having or at risk of having a coagulation related disorder |
| AU2020227825B2 (en) | 2019-02-27 | 2026-03-26 | Stoke Therapeutics, Inc. | Antisense oligomers for treatment of conditions and diseases |
| EP3935581A4 (en) | 2019-03-04 | 2022-11-30 | Iocurrents, Inc. | DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING |
| GB202002202D0 (en) * | 2020-02-18 | 2020-04-01 | Ucl Business Plc | Gene therapy |
| CN115867657A (zh) | 2020-05-11 | 2023-03-28 | 斯托克制药公司 | 用于治疗疾患和疾病的opa1反义寡聚物 |
| EP3982367A1 (en) * | 2020-10-09 | 2022-04-13 | KWS SAAT SE & Co. KGaA | Haplotype-block-based imputation of genomic markers |
| US20240366796A1 (en) * | 2021-07-22 | 2024-11-07 | Altius Institute For Biomedical Sciences | Erythroid Specific Enhancers |
| CN114646664B (zh) * | 2022-05-20 | 2022-08-12 | 领合(南通)新型建材科技有限公司 | 新型复合门窗型材隔热性能质量监测方法与系统 |
| CN115198011A (zh) * | 2022-08-15 | 2022-10-18 | 中日友好医院(中日友好临床医学研究所) | 静脉血栓栓塞症多基因检测试剂盒及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005056837A2 (en) | 2003-11-26 | 2005-06-23 | Applera Corporation | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
| US20070269827A1 (en) | 2006-05-18 | 2007-11-22 | Oklahoma Medical Research Foundation | Predicting and Diagnosing Patients With Autoimmune Disease |
| WO2009151691A2 (en) * | 2008-03-13 | 2009-12-17 | Celera Corporation | Genetic polymorphisms associated wiith venous thrombosis, methods of detection and uses thereof |
| US20120108651A1 (en) * | 2010-11-02 | 2012-05-03 | Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) | Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof |
-
2009
- 2009-03-13 WO PCT/US2009/037069 patent/WO2009151691A2/en not_active Ceased
- 2009-03-13 EP EP09762986.9A patent/EP2276855B1/en active Active
- 2009-03-13 US US12/403,552 patent/US8071291B2/en active Active
- 2009-03-13 CA CA2717045A patent/CA2717045C/en active Active
- 2009-03-13 JP JP2010550884A patent/JP5409658B2/ja active Active
-
2011
- 2011-10-11 US US13/270,936 patent/US20120264692A1/en not_active Abandoned
-
2012
- 2012-12-24 US US13/726,344 patent/US20130274195A1/en not_active Abandoned
-
2013
- 2013-10-10 JP JP2013212559A patent/JP2014003985A/ja not_active Withdrawn
-
2016
- 2016-01-25 US US15/005,179 patent/US20160281164A1/en not_active Abandoned
-
2018
- 2018-12-03 US US16/207,534 patent/US11124834B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011517935A5 (https=) | ||
| DK2721172T5 (en) | TROMBOEMBOLIC DISEASE MARKERS | |
| EP1325963B1 (en) | Method for non-invasive diagnosis of transplantations and transfusions | |
| JP2011517281A5 (https=) | ||
| EP2718486A2 (en) | Methods and compositions of predicting activity of retinoid x receptor modulator | |
| WO2014093825A1 (en) | Personalized biomarkers for cancer | |
| JP2013542735A5 (https=) | ||
| US20180066313A1 (en) | Thromboembolic disease markers | |
| JP6188810B2 (ja) | Ｈｌａ−ｂ＊１３０１対立遺伝子の使用 | |
| KR102559124B1 (ko) | Flt3 유전자 증폭용 조성물 및 이의 용도 | |
| TWI567202B (zh) | 檢測酒精代謝基因之方法及套組 | |
| Sakalar et al. | Higher frequency of rs4977574 (the G Allele) on chromosome 9p21. 3 in patients with myocardial infarction as revealed by PCR-RFLP analysis | |
| KR101157135B1 (ko) | 항응고제의 약물반응과 관련된 유전자의 변이 유전형 결정방법 | |
| Babic et al. | Comparison of performance of three commercial platforms for warfarin sensitivity genotyping | |
| Nuchnoi et al. | Significant association between TIM1 promoter polymorphisms and protection against cerebral malaria in Thailand | |
| CN106048076A (zh) | 用于氯吡格雷个体化用药相关基因snp检测的试剂盒及其检测方法 | |
| EP3292213A1 (en) | Biomarkers for the detection of aspirin insensitivity | |
| Rodrigues et al. | Rapid blood group genotyping by allelic discriminative real-time PCR in multiply-transfused patients. | |
| Izquierdo Álvarez et al. | A deep vein thrombosis caused by 20209C> T mutation in homozygosis of the prothrombin gene in a Caucasian patient | |
| Al-Jaibeji et al. | Allele and genotype frequencies of the two single nucleotide polymorphisms in the VKORC1 gene that are most important for warfarin treatment among Emiratis | |
| JP2016189746A (ja) | プライマー対、プローブ、薬剤耐性ｃ型肝炎ウイルスの検出キット、薬剤耐性ｃ型肝炎ウイルスの検出方法およびｃ型肝炎の予後予測方法 | |
| US9404161B2 (en) | Method of detecting and quantifying coccidioides species | |
| BG4296U1 (bg) | Средство за количествено определяне на мутации в кодон r882 на човешкия dnmt3a ген при хематологични злокачествени заболявания | |
| Albarrán et al. | Analysis of mitochondrial 12S rRNA gene sequence variation in four ethnically defined populations | |
| Izquierdo et al. | A deep vein thrombosis caused by 20209C> T mutation in homozygosis of the prothrombin gene in a Caucasian patient |